Urology practice company Urology Management Associates (UMA) disclosed on Monday the addition of Derek Grimes as senior vice president of its Clinical Research at New Jersey Urology (NJU).
Effective April 2019, Grimes will lead the company's Clinical Research Organization (CRO), oversee operational site functions, profit and loss, clinical management and recruitment as well as be responsible for managing and supporting client relationships in the pharmaceutical, biotech and medical device industries.
Most recently, Grimes has served as vice president of clinical operations at TKL Research in New Jersey, where he oversaw the Research Clinics division.
Previously, Grimes worked for eight years with Columbia and New York Universities in managing and developing clinical trials for the universities.
Orphalan commences Phase 3 study of trientine therapy in Wilson disease
ZAGENO named Frost & Sullivan's 2026 North American Life Sciences E-Commerce Company of the Year
Pharvaris reports Phase 3 success for deucrictibant XR in HAE prophylaxis
Sky Labs presents clinical research outcomes for ring-type blood pressure monitor CART
Etcamah–CDK4/6 inhibitor combination approved in US for ESR1-mutated HR-positive breast cancer
Ionis partner Novartis reports pelacarsen Phase 3 trial misses primary endpoint
Guardant Health wins FDA approval for Guardant360 CDx in advanced breast cancer
4basebio announces expansion of DNA offering for personalised mRNA medicines
Rznomics reports advances in high-efficiency circRNA production in Nucleic Acids Research
Kali Therapeutics' KT501 Investigational New Drug application cleared by US FDA
Thryv Therapeutics licenses new class of SGK1 inhibitors, expanding into neurodegenerative disease
Sensorion secures French approval for Phase I/II SENS-601 hearing-loss trial